GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FunPep Co Ltd (TSE:4881) » Definitions » ROCE %

FunPep Co (TSE:4881) ROCE % : -35.93% (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is FunPep Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. FunPep Co's annualized ROCE % for the quarter that ended in Jun. 2024 was -35.93%.


FunPep Co ROCE % Historical Data

The historical data trend for FunPep Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FunPep Co ROCE % Chart

FunPep Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial -27.26 -25.10 -22.09 -39.01 -38.00

FunPep Co Quarterly Data
Dec17 Dec18 Sep19 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.67 -27.58 -30.15 -30.08 -35.93

FunPep Co ROCE % Calculation

FunPep Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-994.107/( ( (2992.694 - 175.688) + (2491.134 - 76.554) )/ 2 )
=-994.107/( (2817.006+2414.58)/ 2 )
=-994.107/2615.793
=-38.00 %

FunPep Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=-848.084/( ( (2585.216 - 119.561) + (2688.143 - 433.228) )/ 2 )
=-848.084/( ( 2465.655 + 2254.915 )/ 2 )
=-848.084/2360.285
=-35.93 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FunPep Co  (TSE:4881) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


FunPep Co ROCE % Related Terms

Thank you for viewing the detailed overview of FunPep Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


FunPep Co Business Description

Traded in Other Exchanges
N/A
Address
5-8-4 Sendagaya Shibuya-ku, No.7 Mizuho Building 3rd Floor, Tokyo, JPN
FunPep Co Ltd is a biotechnology company focused on functions of peptides to develop business from cosmetics to medical devices and pharmaceutical products. The company develops drugs related to the intractable peptic ulcer disease.

FunPep Co Headlines

No Headlines